SARS-CoV-2 Positive Control (2 x 220 µl)

Validated positive run controls anchor SARS-CoV-2 RT-PCR workflows, and the QIAGEN Positive Control provides a ready-to-use, non-infectious reference material in a 2 x 220 µl vial format. Each vial contains stabilized SARS-CoV-2 target sequences formulated to verify nucleic acid extraction, reverse transcription, and amplification performance in clinical and research molecular testing laboratories.

Intended application: serve as a positive run control in RT-PCR assays targeting SARS-CoV-2 RNA, including QIAstat-Dx Respiratory Panel workflows. Storage: store at -20 °C in single-use aliquots to minimize freeze-thaw cycles; thaw on ice immediately before use and avoid repeated freeze-thaw events. Format: 2 x 220 µl vials of stabilized control material packaged for single-use application per vial.

Pipette 10 µl of control per RT-PCR reaction to confirm assay sensitivity, limit of detection, and reproducibility across reagent lots. The control supplies a defined target sequence for monitoring contamination, pipetting accuracy, and instrument performance, supporting clinical diagnostic validation, research use only protocols, and quality control in high-throughput testing environments.